Next Article in Journal
Lipid Droplets in Cancer: Guardians of Fat in a Stressful World
Previous Article in Journal
Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency
Previous Article in Special Issue
Targeting Transcription Factors for Cancer Treatment
Article Menu

Export Article

Open AccessFeature PaperArticle
Molecules 2018, 23(8), 1938; https://doi.org/10.3390/molecules23081938

Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα

1
Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore
2
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
3
Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan
4
Medicinal Chemistry and Pharmacology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500 007, India
5
Department of Chemistry, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad-500 085, India
6
School of Pharmaceutical Education and Research (SPER), Jamia Hamdard, New Delhi-110 062, India
7
Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02215, USA
8
Division of translational Genomics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Academic Editor: Takaomi Sanda
Received: 22 June 2018 / Revised: 30 July 2018 / Accepted: 31 July 2018 / Published: 3 August 2018
(This article belongs to the Special Issue Transcription Factors as Therapeutic Targets)
View Full-Text   |   Download PDF [1602 KB, uploaded 3 August 2018]   |  

Abstract

The CCAAT enhancer-binding protein α (C/EBPα) plays an important role in myeloid cell differentiation and in the enhancement of C/EBPα expression/activity, which can lead to granulocytic differentiation in acute myeloid leukemia (AML) cells. We found that styryl quinazolinones induce upregulation of C/EBPα expression, and thereby induce myeloid differentiation in human myeloid leukemia cell lines. We screened a series of active styryl quinazolinones and evaluated the structure–activity relationship (SAR) of these small molecules in inducing C/EBPα expression—thereby prompting the leukemic cells to differentiate. We observed that compound 78 causes differentiation at 3 μM concentration, while 1 induces differentiation at 10 μM concentration. We also observed an increase in the expression of neutrophil differentiation marker CD11b upon treatment with 78. Both the C/EBPα and C/EBPε levels were found to be upregulated by treatment with 78. These SAR findings are inspiration to develop further modified styryl quinazolinones, in the path of this novel differentiation therapy, which can contribute to the care of patients with AML. View Full-Text
Keywords: myeloid differentiation; CCAAT/enhancer binding protein α myeloid differentiation; CCAAT/enhancer binding protein α
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Sridhar, R.; Takei, H.; Syed, R.; Kobayashi, I.S.; Hui, L.B.; Kamal, A.; Tenen, D.G.; Kobayashi, S.S. Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα. Molecules 2018, 23, 1938.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top